drugset / Trial / NCT04082975

Efficacy and Safety of NVP-1203 and NVP-1203-R in Patients With Acute Low Back Pain

NCT04082975

Phase 3 Completed 421 enrolled NVP Healthcare
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety NVP-1203 in patients with acute low back pain.

Timeline

Start
2020-01-15
Primary completion
2021-05-24
Completion
2021-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject NVP-1203 Unknown Oral
Comparator NVP-1203-R Unknown Oral

Indications

No indication recorded.